Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates

Pavel Strop(Pfizer (United States)), Arvind Rajpal(Pfizer (United States)), Thomas-Toan Tran(University of Tübingen), Jessica Yu(Pfizer (United States)), Sherman M. Chin(Pfizer (United States)), Kathy Delaria(Pfizer (United States)), Santiago Farias(University of Colorado Health), Ramalakshmi Y. Chandrasekaran(Pfizer (United States)), Caroline Samain(Pfizer (United States)), Magdalena Dorywalska(Pfizer (United States)), Javier Chaparro‐Riggers(Pfizer (United States)), Teresa Wong(Pfizer (United States)), Carole Loo(Pfizer (United States)), Mathias Rickert(Pfizer (United States)), Wei-Hsien Ho(PDL BioPharma (United States)), Stellanie Krimm(Pfizer (United States)), Jeanette Dilley(Pfizer (United States)), Meritxell Galindo Casas(Pfizer (United States)), David L. Shelton(Pfizer (United States)), Dahui Zhou(Pfizer (United States)), Gary F. Filzen(Pfizer (United States)), Andrea Rossi(University of Florence), Jeremy S. Myers(Resolve Therapeutics (United States)), Fang Wang(Shanghai Medical College of Fudan University), Shu‐Hui Liu(Nanjing Agricultural University), Christopher J. O’Donnell(Framingham Heart Study), Yasmina Abdiche(Pfizer (United States)), Jaume Pons(Pfizer (United States)), Russell G. Dushin(Pearl River Community College)
Chemistry & Biology
February 1, 2013
Cited by 498


Related Papers